Coya Therapeutics Past Earnings Performance
Past criteria checks 0/6
Coya Therapeutics's earnings have been declining at an average annual rate of -34.2%, while the Biotechs industry saw earnings growing at 14.7% annually.
Key information
-34.2%
Earnings growth rate
3.5%
EPS growth rate
| Biotechs Industry Growth | 17.0% |
| Revenue growth rate | n/a |
| Return on equity | -31.8% |
| Net Margin | -168.1% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
No updates
Recent updates
Coya Therapeutics (NASDAQ:COYA) Is In A Good Position To Deliver On Growth Plans
Mar 26
Coya Therapeutics In Catbird Seat Following Dr. Reddy's Licensing Deal
Feb 13Coya Therapeutics: Interesting Early Data In CNS Diseases, Very Low Cash Position
Jan 13We Think Coya Therapeutics (NASDAQ:COYA) Needs To Drive Business Growth Carefully
Sep 06Here's Why We're Watching Coya Therapeutics' (NASDAQ:COYA) Cash Burn Situation
May 17Revenue & Expenses BreakdownBeta
How Coya Therapeutics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 6 | -10 | 9 | 2 |
| 31 Dec 23 | 6 | -8 | 8 | 0 |
| 30 Sep 23 | 0 | -12 | 6 | 5 |
| 30 Jun 23 | 0 | -13 | 6 | 4 |
| 31 Mar 23 | 0 | -13 | 6 | 5 |
| 31 Dec 22 | 0 | -12 | 5 | 0 |
| 30 Sep 22 | 0 | -11 | 5 | 5 |
| 30 Jun 22 | 0 | -8 | 4 | 4 |
| 31 Mar 22 | 0 | -6 | 3 | 3 |
| 31 Dec 21 | 0 | -5 | 2 | 3 |
Quality Earnings: COYA is currently unprofitable.
Growing Profit Margin: COYA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: COYA is unprofitable, and losses have increased over the past 5 years at a rate of 34.2% per year.
Accelerating Growth: Unable to compare COYA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: COYA is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-14.4%).
Return on Equity
High ROE: COYA has a negative Return on Equity (-31.81%), as it is currently unprofitable.